Roberta Gualtierotti: Point-of-Care SPR Device for Rapid Detection of Anti-PEG Antibodies
Roberta Gualtierotti, Associate Professor of Internal Medicine at the University of Milan, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in scientific reports, nature, adding:
“Excited to share this new work on a point-of-care SPR device for rapid detection of anti-PEG antibodies by Laura Pasquardini et al
PEGylation is widely used in biologic drugs, including extended half-life FVIII products for hemophilia A, to improve safety and efficacy.
However, PEG itself may trigger anti-PEG antibodies, potentially causing loss of treatment efficacy.
Our study presents a portable, low-cost platform capable of detecting anti-PEG IgG and IgM in just 15 minutes from human plasma, with nanomolar sensitivity and strong agreement with other methods (SPR and ELISA).
A step forward toward personalized monitoring of PEG immunogenicity and safer use of PEGylated therapies.”
Title: Development of a portable device for the detection of anti-PEG antibodies in human plasma
Authors: Laura Pasquardini, Nunzio Cennamo, Camilla Rossi, Roberto Canteri, Lia Vanzetti, Marten Beeg, Roberta Gualtierotti, Luca Pasquale Renzullo, Ines Tavoletta, Lucia Schiavone, Carla Valsecchi, Chiara Suffritti, Flora Peyvandi, Marco Gobbi, Luigi Zeni
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 11, 2026, 02:54Tareq Abadl: The Ultimate Guide to Clinically Significant Antibodies
-
Aug 10, 2026, 17:35Chokri Ben Lamine: Balancing Holistic Care and Precision in Hematology
-
Aug 10, 2026, 17:14Anna Stanizzi: Patient Blood Management as a New Model of Personalized Care
-
Aug 10, 2026, 17:12Odong Christopher: New Research on Ischemic Stroke Prediction in Uganda
-
Aug 10, 2026, 16:58Jeff Szer AM: Advancing the Management of Paroxysmal Nocturnal Hemoglobinuria
-
Aug 10, 2026, 16:51Suebsarn Ruksakulpiwat։ A New Milestone in the Development of the Stroke Risk Screening Scales
-
Aug 10, 2026, 16:09Preetie Shetty Akkunje: Making Stroke Rehabilitation Accessible in Low-Resource Settings
-
Aug 10, 2026, 15:50The Next Antithrombotic Frontier: GPVI Inhibitors Beyond Aspirin
-
Aug 10, 2026, 15:47Edward Lee Carter: 61% of Patients on Reduced-Dose Apixaban Did Not Meet Label Criteria